 SAN DIEGO, Oct. 27, 2020 PRNewswire -- Mirati Therapeutics, Inc. Nasdaq: MRTX today announced the pricing of an underwritten public offering of 4,335,397 shares of its common stock at a price to the public of 202.00 per share, which consists of 3,960,397 shares to be sold by Mirati... 